Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BROLUCIZUMAB vs BUDESONIDE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

BROLUCIZUMAB vs BUDESONIDE: Safety Overview

Metric BROLUCIZUMAB BUDESONIDE
Total FAERS Reports 682 25,122
Deaths Reported 41 987
Death Rate 6.0% 3.9%
Hospitalizations 105 6,421
Average Patient Age 69.5 yrs 54.6 yrs
% Female Patients 57.1% 58.1%
FDA Approval Date N/A Apr 12, 2023
Manufacturer Novartis Pharmaceuticals Corporation Mylan Pharmaceuticals Inc.
Route INTRAVITREAL RESPIRATORY (INHALATION)
Marketing Status N/A Discontinued